RNS Number : 6662W
Impact Healthcare REIT PLC
17 July 2024
 
17 July 2024

Impact Healthcare REIT plc

("Impact" or the "Company" or, together with its subsidiaries, the "Group")

ā€‹

NOTICE OF HALF YEAR RESULTS AND INVESTOR PRESENTATION

ā€‹

Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust which gives investors exposure to a diversified portfolio of UK healthcare real estate assets, in particular care homes, will announce its half year results for the six months ended 30 June 2024 on Thursday, 8 August 2024.

 

A Company presentation for analysts and investors will take place on the day at 9.00am (BST) via a live webcast and conference call.

 

To register for the live webcast, please use this link:

https://stream.brrmedia.co.uk/broadcast/6695223836704318d5bcf290

 

The conference call dial-in is available using the below details:

Phone number:

+44 (0) 33 0551 0200

Participant access code:

Impact Healthcare REIT Half Year Results

 

If you would like to ask your questions verbally, please use the dial in number. Alternatively, you can type questions into the webcast question box.

 

The presentation will also be accessible on demand later in the day on the Company's website: www.impactreit.uk

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Impact Health Partners LLP


Via H/Advisors Maitland

Andrew Cowley



Mahesh Patel



David Yaldron









Jefferies International Limited


020 7029 8000

Tom Yeadon

tyeadon@jefferies.com


Ollie Nott

onott@jefferies.com








Winterflood Securities Limited


020 3100 0000

Neil Langford

neil.langford@winterflood.com


Joe Winkley

joe.winkley@winterflood.com








H/Advisors Maitland (Communications advisor)

impacthealth-maitland@h-advisors.global


James Benjamin


07747 113 930

Rachel Cohen


020 7379 5151

Billy Moran


020 7379 5151

 

The Company's LEI is 213800AX3FHPMJL4IJ53.

 

Further information on Impact Healthcare REIT plc is available at www.impactreit.uk.

 

NOTES:

Impact Healthcare REIT plc acquires, renovates, extends and redevelops high quality healthcare real estate assets in the UK and lets these assets on long-term full repairing and insuring leases to high-quality established healthcare operators which offer good quality care, under leases which provide the Company with attractive levels of rent cover.

 

The Company aims to provide shareholders with an attractive sustainable return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified and resilient portfolio of UK healthcare real estate assets, in particular care homes for the elderly.

 

The Company's dividend policy is to seek to maintain a progressive dividend that is covered by adjusted earnings.

 

On this basis, the target total dividend for the year ending 31 December 2024 is 6.95 pence per share*, a 0.18 pence increase over the 6.77 pence in dividends paid or declared per ordinary share for the year ended 31 December 2023.

 

The Group's Ordinary Shares trade on the main market of the London Stock Exchange, premium segment. The Company is a constituent of the FTSE EPRA/NAREIT index.

*     This is a target only and not a profit forecast. There can be no assurance that the target will be met and it should not be taken as an indicator of the Company's expected or actual results.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORDGGDRRSBDGSL